Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix vs Goserelin/Bicalutamide for Prostate Size Reduction in Prostate Cancer
NCT00833248Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Apr 2009
- Primary completion
- Sep 2011
- Modality
- Peptides, Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of degarelix in prostate cancer (PCa), sponsored by Ferring Pharmaceuticals. Started Apr 2009; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00833248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00833248.